Kingfa Science Q1 FY27: Profit up 111%, margin widens

Introduction

Kingfa Science & Technology reported a sharp improvement in profitability for the first quarter of FY27, backed by strong revenue growth and wider operating margins. The company’s results were filed with stock exchanges on August 14, 2026. Net profit rose to ₹802 crore in Q1FY27, up from ₹380 crore in the corresponding quarter last year. Revenue also expanded meaningfully, rising 49% year-on-year to ₹6,886 crore from ₹4,619 crore. The numbers point to a quarter where both demand and operating efficiency moved in the same direction. Management commentary was not provided in the shared disclosure, but the reported metrics highlight stronger operating leverage. The quarter is also notable for the continued dominance of domestic sales in the revenue mix.

Q1FY27 headline numbers

The key headline was profit growth that outpaced revenue growth. Net profit climbed to ₹802 crore, compared with ₹380 crore in Q1FY26. Revenue increased to ₹6,886 crore from ₹4,619 crore over the same period, translating into 49% year-on-year growth. Total comprehensive income for the quarter was reported at ₹803 crore, broadly in line with the net profit figure. Basic earnings per share (EPS) stood at ₹59.19 for Q1FY27, compared with ₹43.65 in Q4FY26. The step-up in EPS suggests the improved profitability also translated into higher per-share earnings over the immediately preceding quarter.

Operating performance and margin expansion

Operating efficiency strengthened during the quarter as reflected in EBITDA and margins. EBITDA increased to ₹1,100 crore from ₹58.1 crore (₹581 million) in the prior-year period, as stated in the update. The EBITDA margin widened to 16.12% from 12.58% in Q1FY26. A margin expansion of this scale typically indicates better cost management relative to sales volume, and the filing explicitly linked it to improved operating leverage. In practical terms, the company generated more operating profit per rupee of revenue than it did a year ago. The margin improvement is a key variable investors track because it can signal whether growth is being achieved efficiently.

Domestic market continued to drive growth

Domestic sales remained the primary growth driver in Q1FY27. The company reported that domestic sales accounted for 92% of total revenue for the quarter. Domestic sales stood at ₹6,349 crore, up from ₹4,251 crore in Q1FY26. That expansion in domestic revenue explains most of the year-on-year increase in the top line. The concentration also indicates that the company’s near-term performance is closely linked to domestic demand conditions and pricing dynamics. While the update does not specify end markets, the heavy domestic share provides context for how the revenue acceleration was achieved.

Exports grew but stayed a smaller share

Export sales contributed 8% of total revenue in Q1FY27. Exports rose to ₹536 crore from ₹368 crore in the same period last year. The export growth is meaningful in absolute terms, but the overall mix shows exports remain secondary to the domestic market for this quarter. The 92:8 split also suggests that changes in domestic demand will likely have a larger impact on quarterly outcomes than fluctuations in export orders. Still, the year-on-year improvement in exports adds another growth channel and diversifies the revenue base, even if modestly.

What the EPS and comprehensive income indicate

Basic EPS was reported at ₹59.19 for Q1FY27, compared with ₹43.65 in Q4FY26. The disclosure also reported total comprehensive income of ₹803 crore. Comprehensive income typically includes net profit plus other income items recorded directly in equity, but the filing only provided the headline figure. The closeness of comprehensive income (₹803 crore) to net profit (₹802 crore) suggests limited additional items impacting the quarter’s broader income measure, based on the numbers stated. Investors often look at EPS trends alongside margins to gauge whether profit growth is translating into per-share outcomes.

Exchange filing, board meeting, and earnings calendar

The results were filed with stock exchanges on August 14, 2026. The same date also appears in the company’s board meeting schedule, which referenced consideration and approval of unaudited financial results for the quarter ended June 30, 2026, along with a recommendation of final dividend for the year ended March 31, 2026. Separately, a board meeting entry dated Aug 14, 2026 referenced “Audited Results & Final Dividend”. Another entry in the provided data shows a meeting date of Aug 13, 2026 announced on Aug 6, 2026 with the purpose “Audited Results & Final Dividend”. These entries together indicate multiple exchange communications around the mid-August board meeting and results process.

Snapshot of earlier reported financials for Kingfa Science & Technology (India) Ltd

In the provided disclosures, Kingfa Science & Technology (India) Limited also reported audited standalone financial results for FY26, approved by the Board on May 29, 2026. For FY26, the company reported net profit of ₹185.26 crore (₹18,525.85 lakh) and revenue from operations of ₹1,995.55 crore (₹1,99,555.15 lakh). For the quarter ended March 31, 2026, net profit was ₹59.15 crore (₹5,914.93 lakh). The filing also stated Q4 EBITDA rose to ₹81.0 crore (₹810 million) with margins expanding to 14%. These numbers provide additional context on the company’s prior reported performance and the cadence of statutory approvals and publications.

Key data table (all amounts in ₹ crore)

Dates and regulatory trail in the disclosures

Why the quarter matters for investors

The Q1FY27 numbers show a combination of rapid top-line expansion and a clear improvement in operating margin. Revenue growth of 49% is substantial, and the widening EBITDA margin to 16.12% indicates improved conversion of sales into operating profit. The sales mix also matters, with 92% of revenue coming from domestic sales, signalling that domestic demand trends are central to the current performance. The jump in EPS from ₹43.65 in Q4FY26 to ₹59.19 in Q1FY27, as reported, adds a per-share lens to the profit expansion. Investors typically watch whether such margin gains persist across subsequent quarters, especially when growth is concentrated in one geography.

Conclusion

Kingfa Science & Technology’s Q1FY27 filing dated August 14, 2026 showed higher revenue, sharply higher net profit, and a stronger operating margin compared with the year-ago quarter. Domestic sales remained the dominant contributor, while exports also increased year-on-year. The company’s disclosed board meeting schedule around mid-August, along with earlier FY26 approvals and publications, sets the regulatory context for the results cycle. The next key items for market participants will be any further exchange updates tied to the board’s decisions, including the stated consideration of unaudited quarterly results and a final dividend recommendation for FY ended March 31, 2026.